Our findings provide new insight on the versatile role of MeCP2 which is known to be critical in regulating gene imprinting (49), transcriptional activation and repression (50) in disparate conditions that range from autism to cancer (4, 51, 52). The gene discussed is MECP2; the disease is cancer.